ArticleEuropean journal of haematology2025

Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study.

C Bucelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.